Deanna S. Mitchell
Distinguished in Neuroblastoma

Dr. Deanna S. Mitchell

Pediatric Hematology Oncology
Corewell Health
Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE
35 Michigan Street Northeast, Floor 2, 
Grand Rapids, MI 
On Staff At
Clinical Trials:Currently Recruiting for 2 Trials
39 Years of Experience
Distinguished in Neuroblastoma
Corewell Health
Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE
35 Michigan Street Northeast, Floor 2, 
Grand Rapids, MI 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Deanna Mitchell is a Pediatric Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Mitchell has been practicing medicine for over 39 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Neuroblastoma, Hemophilic Arthropathy, Hemophilia A, and Hereditary Neuroblastoma.

Her clinical research consists of co-authoring 13 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 9 articles and participated in 6 clinical trials in the study of Neuroblastoma.

Graduate Institution
KU School Of Medicine - Wichita, 1987
Residency
University of North Carolina Hospitals
Specialties
Pediatric Hematology Oncology
Licenses
Pediatric Hematology-Oncology in MI
Board Certifications
American Board Of Pediatrics
Fellowships
University of Michigan Hospitals and Health Centers
Hospital Affiliations
Corewell Health Grand Rapids Hospitals
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
McLaren Health
  • HMO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Meridian Choice
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Priority Health
  • HMO
  • POS
Spectrum Priority Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
University of Michigan Health
  • HMO
  • INSURANCE PLAN
  • MEDICARE MAPD
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE
35 Michigan Street Northeast, Floor 2, Grand Rapids, MI 49503
Call: 616-267-1925
Other Locations
Corewell Health Grand Rapids Hospitals Pediatric Hematology/Oncology - Traverse City
217 South Madison Street, Traverse City, MI 49684
Call: 616-267-1925

Additional Areas of Focus

Dr. Mitchell has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
NMTT- Neuroblastoma Maintenance Therapy Trial Using Difluoromethylornithine (DFMO)
Enrollment Status: Recruiting
Publish Date: September 22, 2025
Intervention Type: Drug
Study Drug: Difluoromethylornithine (DFMO)
Study Phase: Phase 2
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma
A Study Using Molecular Guided Therapy With Induction Chemotherapy Followed by a Randomized Controlled Trial of Standard Immunotherapy With or Without DFMO Followed by DFMO Maintenance for Subjects With Newly Diagnosed High-Risk Neuroblastoma
Enrollment Status: Recruiting
Publish Date: August 27, 2025
Intervention Type: Drug
Study Drugs: Ceritinib, Dasatinib, Sorafenib, Vorinostat, DFMO
Study Phase: Phase 2
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Molecular-guided Therapy for the Treatment of Patients With Relapsed and Refractory Childhood Cancers
Enrollment Status: Completed
Publish Date: November 03, 2025
Intervention Type: Device
Study Phase: Not Applicable
An Intermediate Expanded Use Trial of DFMO
An Intermediate Expanded Use Trial of DFMO
Enrollment Status: Available
Publish Date: August 07, 2025
Intervention Type: Drug
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Prospective Multi-Center Evaluation of the Duration of Therapy for Thrombosis in Children
Enrollment Status: Completed
Publish Date: June 18, 2025
Intervention Type: Other
Study Phase: Phase 3
A Phase I/II Trial of DFMO in Combination With Bortezomib in Patients With Relapsed or Refractory Neuroblastoma
A Phase I/II Trial of DFMO in Combination With Bortezomib in Patients With Relapsed or Refractory Neuroblastoma
Enrollment Status: Completed
Publish Date: August 06, 2024
Intervention Type: Drug
Study Drugs: Difluoromethylornithine, Bortezomib
Study Phase: Phase 1/Phase 2
A Phase I Trial of Tolcapone Alone and in Combination With Oxaliplatin in Patients With Relapsed or Refractory Neuroblastoma
A Phase I Trial of Tolcapone Alone and in Combination With Oxaliplatin in Patients With Relapsed or Refractory Neuroblastoma
Enrollment Status: Terminated
Publish Date: August 06, 2024
Intervention Type: Drug
Study Phase: Phase 1
A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.
A Phase II Trial of Nifurtimox for Refractory or Relapsed Neuroblastoma or Medulloblastoma.
Enrollment Status: Completed
Publish Date: August 06, 2024
Intervention Type: Drug
Study Drugs: Nifurtimox, Cyclophosphamide, Topotecan
Study Phase: Phase 2
View 6 Less Clinical Trials

13 Total Publications

Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 26, 2023
View All 13 Publications
Similar Doctors
Kristy L. Pilbeam
Advanced in Neuroblastoma
Dr. Kristy L. Pilbeam
Pediatric Hematology Oncology
Advanced in Neuroblastoma
Dr. Kristy L. Pilbeam
Pediatric Hematology Oncology

Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE

35 Michigan Street Northeast, Floor 2, 
Grand Rapids, MI 
 (0.1 miles away)
616-267-1925
Experience:
15+ years
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kristy Pilbeam is a Pediatric Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Pilbeam has been practicing medicine for over 15 years and is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Langerhans Cell Histiocytosis, Ewing Sarcoma, and Hereditary Neuroblastoma. Dr. Pilbeam is currently accepting new patients.

Jessica M. Foley
Experienced in Neuroblastoma
Dr. Jessica M. Foley
Pediatric Hematology Oncology
Experienced in Neuroblastoma
Dr. Jessica M. Foley
Pediatric Hematology Oncology

Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE

35 Michigan Street Northeast, Floor 2, 
Grand Rapids, MI 
 (0.1 miles away)
616-267-1925
Experience:
19+ years
Languages Spoken:
English
See accepted insurances

Jessica Foley is a Pediatric Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Foley has been practicing medicine for over 19 years and is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Hereditary Spherocytosis, Hemophilic Arthropathy, and Hemophilia A.

Matthew G. Pridgeon
Experienced in Neuroblastoma
Dr. Matthew G. Pridgeon
Pediatric Hematology Oncology
Experienced in Neuroblastoma
Dr. Matthew G. Pridgeon
Pediatric Hematology Oncology

Corewell Health Grand Rapids Hospitals Pediatric Cancer Hematology - 35 Michigan St NE

35 Michigan Street Northeast, Floor 2, 
Grand Rapids, MI 
 (0.1 miles away)
616-267-1925
Experience:
16+ years
Languages Spoken:
English
See accepted insurances

Matthew Pridgeon is a Pediatric Hematologist Oncology provider in Grand Rapids, Michigan. Dr. Pridgeon has been practicing medicine for over 16 years and is rated as an Advanced provider by MediFind in the treatment of Neuroblastoma. His top areas of expertise are Sickle Cell Disease, Hereditary Spherocytosis, Hemoglobin SC Disease, and Acute Lymphoblastic Leukemia (ALL).

VIEW MORE NEUROBLASTOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Mitchell's expertise for a condition
ConditionClose
    • Distinguished
    • Neuroblastoma
      Dr. Mitchell is
      Distinguished
      . Learn about Neuroblastoma.
      See more Neuroblastoma experts
    • Advanced
    • Acute Lymphoblastic Leukemia (ALL)
      Dr. Mitchell is
      Advanced
      . Learn about Acute Lymphoblastic Leukemia (ALL).
      See more Acute Lymphoblastic Leukemia (ALL) experts
    • Embryonal Tumor with Multilayered Rosettes
      Dr. Mitchell is
      Advanced
      . Learn about Embryonal Tumor with Multilayered Rosettes.
      See more Embryonal Tumor with Multilayered Rosettes experts
    • Febrile Neutropenia
      Dr. Mitchell is
      Advanced
      . Learn about Febrile Neutropenia.
      See more Febrile Neutropenia experts
    • Hemophilia A
      Dr. Mitchell is
      Advanced
      . Learn about Hemophilia A.
      See more Hemophilia A experts
    • Hemophilia B
      Dr. Mitchell is
      Advanced
      . Learn about Hemophilia B.
      See more Hemophilia B experts
    • Hemophilic Arthropathy
      Dr. Mitchell is
      Advanced
      . Learn about Hemophilic Arthropathy.
      See more Hemophilic Arthropathy experts
    View All 8 Advanced Conditions
    • Experienced
    • Adult Soft Tissue Sarcoma
      Dr. Mitchell is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • Alpha Thalassemia
      Dr. Mitchell is
      Experienced
      . Learn about Alpha Thalassemia.
      See more Alpha Thalassemia experts
    • Aplastic Anemia
      Dr. Mitchell is
      Experienced
      . Learn about Aplastic Anemia.
      See more Aplastic Anemia experts
    • Beta Thalassemia
      Dr. Mitchell is
      Experienced
      . Learn about Beta Thalassemia.
      See more Beta Thalassemia experts
    • Blood Clots
      Dr. Mitchell is
      Experienced
      . Learn about Blood Clots.
      See more Blood Clots experts
    • Cantu Syndrome
      Dr. Mitchell is
      Experienced
      . Learn about Cantu Syndrome.
      See more Cantu Syndrome experts
    View All 33 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.